GlassScriptPhysician profile
Marc Steven Benison
NPI 1134669385
$1,401.47
in general payments reported to CMS, 2019-2025
18 companies · $305 in 2025
The $305 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $58.25 · 2021: $275 · 2022: $323 · 2023: $165 · 2024: $274 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $250.66 | 2021-2025 | Bexsero, Penmenvy, Pediarix |
| Ironshore Pharmaceuticals INC. | $237.69 | 2020-2024 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $170.38 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $142.65 | 2020-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Pfizer INC. | $105.72 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.92 | 2020-2021 | |
| Sanofi Pasteur INC. | $71.86 | 2021-2025 | |
| Seqirus USA INC | $56.92 | 2021-2024 | Flucelvax |
| Astrazeneca Pharmaceuticals LP | $51.57 | 2021-2023 | Flumist Quadrivalent |
| Kaleo, INC. | $40.46 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $38.60 | 2025 | Jornay Pm |
| Aimmune Therapeutics, INC. | $34.59 | 2021 | |
| Sobi, INC | $32.16 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $23.64 | 2025 | Koselugo |
| Mylan Pharmaceuticals INC. | $17.78 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $16.48 | 2025 | Immunocap |
| Tris Pharma INC | $15.90 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Benison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.